Skip to main content
Year archive

STARPHARMA HOLDINGS LIMITED — 2024 filings

All 67 regulatory filings released by STARPHARMA HOLDINGS LIMITED (SPL) in 2024, sourced directly from the official regulator.

67 Filings
2024 Period
2024 filings (67)
Filing Released Lang
SPL receives positive FDA feedback on DEP SN38 for PROC 3 pages 178.5KB
Regulatory Filings
2024-12-18 English
Notification regarding unquoted securities - SPL 6 pages 19.2KB
Share Issue/Capital Change
2024-12-11 English
Change of Director's Interest Notice - Ms Cheryl Maley 2 pages 319.6KB
Director's Dealing
2024-12-11 English
DEP Presentation at Radiopharmaceuticals Summit 30 pages 2.0MB
Investor Presentation
2024-12-03 English
Results of 2024 Reconvened Annual General Meeting 2 pages 144.4KB
Declaration of Voting Results & Voting Rights Announcements
2024-11-28 English
AGM Notice of Reconvened Meeting 2 pages 125.1KB
AGM Information
2024-11-26 English
AGM Chair's address and CEO's presentation 43 pages 2.7MB
AGM Information
2024-11-25 English
Results of 2024 Annual General Meeting 2 pages 150.4KB
Declaration of Voting Results & Voting Rights Announcements
2024-11-25 English
DEP SN38 Results Showcased at GI Cancer Conference 4 pages 1.7MB
Capital/Financing Update
2024-11-20 English
Bell Potter Healthcare Conference Presentation 19 pages 2.0MB
Investor Presentation
2024-11-17 English
Change of Director's Interest Notice 2 pages 300.7KB
Director's Dealing
2024-11-05 English
Notification regarding unquoted securities - SPL 6 pages 19.1KB
Share Issue/Capital Change
2024-10-31 English
Quarterly Activities/Appendix 4C Cash Flow Report 6 pages 654.4KB
Interim / Quarterly Report
2024-10-30 English
Australian Microcap Conference Presentation 30 pages 2.5MB
Investor Presentation
2024-10-28 English
Notice of Annual General Meeting/Proxy Form 24 pages 1.7MB
AGM Information
2024-10-27 English
Application for quotation of securities - SPL 6 pages 18.3KB
Share Issue/Capital Change
2024-10-24 English
Change of Director's Interest Notice - R Thomas 2 pages 300.7KB
Director's Dealing
2024-10-23 English
SPL7013 Nasal Spray Australia Update 2 pages 171.8KB
Regulatory Filings
2024-10-17 English
Notification of cessation of securities - SPL 4 pages 14.8KB
Share Issue/Capital Change
2024-10-02 English
Date of Annual General Meeting 2024 1 page 145.3KB
AGM Information
2024-10-02 English
Change of Director's Interest Notice - Dr Russell Basser 2 pages 308.1KB
Director's Dealing
2024-09-15 English
Starpharma Receives $5.5M R&D Tax Incentive Refund 2 pages 137.9KB
Regulatory Filings
2024-09-11 English
Ceasing to be a substantial holder 4 pages 245.5KB
Major Shareholding Notification
2024-09-08 English
Change in Director's Interest Notice - R Thomas 2 pages 172.6KB
Director's Dealing
2024-09-01 English
Change in Director's Interest Notice - David McIntyre 2 pages 171.6KB
Director's Dealing
2024-09-01 English
Application for quotation of securities - SPL 6 pages 18.3KB
Capital/Financing Update
2024-08-27 English
Change in substantial holding 4 pages 235.5KB
Major Shareholding Notification
2024-08-26 English
Annual Report to shareholders 103 pages 15.9MB
Annual Report
2024-08-21 English
Appendix 4G and Corporate Governance Statement 22 pages 3.2MB
Governance Information
2024-08-21 English
Change in substantial holding 6 pages 129.2KB
Major Shareholding Notification
2024-08-15 English
Change in substantial holding 4 pages 230.6KB
Major Shareholding Notification
2024-08-01 English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 666.5KB
Interim / Quarterly Report
2024-07-29 English
Application for quotation of securities - SPL 8 pages 23.6KB
Share Issue/Capital Change
2024-07-01 English
Change in substantial holding 4 pages 228.3KB
Major Shareholding Notification
2024-07-01 English
Change in Director's Interest Notice - Jeff Davies 2 pages 200.5KB
Director's Dealing
2024-06-30 English
Change in substantial holding 7 pages 114.5KB
Major Shareholding Notification
2024-06-27 English
Change in Director's Interest Notice - R Thomas 2 pages 243.7KB
Director's Dealing
2024-06-26 English
Change in Director's Interest Notice - L Cheng 2 pages 207.0KB
Director's Dealing
2024-06-26 English
Change in substantial holding 4 pages 229.6KB
Major Shareholding Notification
2024-06-24 English
Change in Director's Interest Notice - R Thomas 2 pages 228.9KB
Director's Dealing
2024-06-20 English
Notification regarding unquoted securities - SPL 6 pages 19.3KB
Share Issue/Capital Change
2024-06-10 English
DEP presentation at SNMMI radiopharmaceuticals conference 3 pages 899.5KB
Investor Presentation
2024-06-10 English
DEP irinotecan presentation at ASCO 2024 Annual Meeting 13 pages 1.2MB
Investor Presentation
2024-06-03 English
DEP cabazitaxel presentation at ASCO 2024 Annual Meeting 15 pages 1.2MB
Investor Presentation
2024-06-02 English
Change in Director's Interest Notice - R Thomas 2 pages 212.8KB
Director's Dealing
2024-05-29 English
Change in Director's Interest Notice - Cheryl Maley 2 pages 183.5KB
Director's Dealing
2024-05-29 English
Positive final DEP irinotecan Phase 2 clinical trial results 8 pages 276.3KB
Regulatory Filings
2024-05-26 English
Starpharma Business Update 35 pages 2.1MB
Regulatory Filings
2024-05-21 English
Investor Webinar Notification - SPL Business Update 2 pages 156.2KB
Investor Presentation
2024-05-19 English
Change in substantial holding 4 pages 229.1KB
Major Shareholding Notification
2024-05-15 English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 374.1KB
Interim / Quarterly Report
2024-04-29 English
Change in Director's Interest Notice - R Thomas 2 pages 184.3KB
Director's Dealing
2024-04-16 English
Change in Director's Interest Notice - R Basser 2 pages 174.1KB
Director's Dealing
2024-04-15 English
Change in Director's Interest Notice - R Thomas 2 pages 172.0KB
Director's Dealing
2024-04-14 English
Starpharma and Medicxi Partnership Petalion Therapeutics 3 pages 200.5KB
Capital/Financing Update
2024-04-07 English
Investor Webinar Notification SPL Medicxi Partnership 2 pages 153.4KB
Investor Presentation
2024-04-07 English
Half Yearly Report and Accounts 23 pages 1.6MB
Interim / Quarterly Report
2024-02-27 English
VivaGel BV US FDA Appeal Outcome 2 pages 218.8KB
Regulatory Filings
2024-02-18 English
Application for quotation of securities - SPL 7 pages 20.2KB
Share Issue/Capital Change
2024-02-05 English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 375.3KB
Interim / Quarterly Report
2024-01-30 English
Viraleze shows antiviral efficacy in COVID-19 patients 5 pages 329.8KB
Regulatory Filings
2024-01-28 English
VivaGel BV sales and distribution agreement MENA region 2 pages 255.2KB
Capital/Financing Update
2024-01-21 English
DEP cabazitaxel data presentation at ASCO GI cancer meeting 4 pages 1.8MB
Investor Presentation
2024-01-18 English
Notification regarding unquoted securities - SPL 7 pages 30.9KB
Share Issue/Capital Change
2024-01-11 English
Appendix 3X - Cheryl Maley 2 pages 243.6KB
Director's Dealing
2024-01-11 English
Final Director's Interest Notice - J Fairley 2 pages 254.4KB
Director's Dealing
2024-01-11 English
Notification of cessation of securities - SPL 4 pages 23.9KB
Regulatory Filings
2024-01-11 English